They discuss the challenges of distributing temperature- and light-sensitive investigational medicinal products, the hidden cost of logistics failures, and why quality should not be compromised when limited clinical material and years of development are at risk. 

The conversation also examines how trust is built through references, communication, transparency and a genuine understanding of the science behind each shipment. Their key message is that stronger outcomes begin when biotech and logistics teams understand the product, the risks and each other’s responsibilities. 

The episode goes live October 29, 2026.